Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Dec 19;22(1):350.
doi: 10.1186/s13054-018-2200-0.

Response to "Adjuvant vitamin C in cardiac arrest patients undergoing renal replacement therapy: an appeal for a higher high-dose"

Angelique M E Spoelstra-de Man  1 , Harm-Jan de Grooth  2 , Paul W G Elbers  2 , Heleen M Oudemans-van Straaten  2
Affiliations
Comment

Response to "Adjuvant vitamin C in cardiac arrest patients undergoing renal replacement therapy: an appeal for a higher high-dose"

Angelique M E Spoelstra-de Man et al. Crit Care. .
No abstract available

Keywords: Cardiac arrest; Continuous renal replacement therapy; Pharmacokinetics; Vitamin C.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Not applicable.

Consent for publication

All authors have reviewed the final version of the manuscript and approve the manuscript for publication.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Plasma concentrations of vitamin C in five patients treated with 1 g intravenous vitamin C twice daily. Patient 5 was treated with CVVH
See this image and copyright information in PMC

Comment on

References

    1. Honore PM, De Bels D, Preseau T, Redant S, Attou R, Spapen HD. Adjuvant vitamin C in cardiac arrest patients undergoing renal replacement therapy: an appeal for a higher high-dose. Crit Care. 2018;22(1):207. doi: 10.1186/s13054-018-2115-9. - DOI - PMC - PubMed
    1. Fowler AA, III, Syed AA, Knowlson S, Sculthorpe R, Farthing D, DeWilde C, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med. 2014;12:32. doi: 10.1186/1479-5876-12-32. - DOI - PMC - PubMed
    1. Morena M, Cristol JP, Bosc JY, Tetta C, Forret G, Leger CL, et al. Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant. 2002;17(3):422–427. doi: 10.1093/ndt/17.3.422. - DOI - PubMed
    1. Story DA, Ronco C, Bellomo R. Trace element and vitamin concentrations and losses in critically ill patients treated with continuous venovenous hemofiltration. Crit Care Med. 1999;27(1):220–223. doi: 10.1097/00003246-199901000-00057. - DOI - PubMed
    1. de Grooth HJ, Manubulu-Choo WP, Zandvliet AS, Spoelstra-de Man AME, Girbes AR, Swart EL, et al. Vitamin C pharmacokinetics in critically ill patients: a randomized trial of four IV regimens. Chest. 2018;153(6):1368–1377. doi: 10.1016/j.chest.2018.02.025. - DOI - PubMed